R. Loch Macdonald
University of Toronto
St Michael Hospital
Division of Neurosurgery
Keenan Research Centre
Canada
Name/email consistency: high
- Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage. Macdonald, R.L. Expert. Opin. Investig. Drugs (2008)
- Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Macdonald, R.L., Kassell, N.F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S., Pasqualin, A. Stroke (2008)
- Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Macdonald, R.L., Pluta, R.M., Zhang, J.H. Nat. Clin. Pract. Neurol (2007)